Balanitis (balanoposthitis) Management
Balanitis is managed by addressing predisposing hygiene factors, determining likely etiology, and using targeted topical or oral therapy based on the cause. [1] A more specific diagnosis is often possible from clinical features, but persistent or diagnostic-uncertain disease requires further evaluation including possible biopsy. [1]
Diagnostic Approach and Assessment
Balanitis is a descriptive term describing inflammation of the glans and often the prepuce. [1] An STI cause should be considered when presentation suggests an STI phenotype, and a full screen for common STIs is recommended when an STI is suspected. [1] Diagnostic evaluation should include targeted testing when uncertainty exists or when severe disease is present. [1] Recommended investigations include the following: [1]
- Sub-preputial swab for Candida spp and bacterial culture to exclude infective causes or superinfection. [1]
- Urinalysis for glucose when candidal infection is suspected. [1]
- Herpes simplex virus NAAT when ulceration is present. [1]
- Treponemal testing and/or dark ground examination for spirochetes when an ulcer is present, with syphilis serology follow-up to 3 months. [1]
- Microscopy or NAAT for Trichomonas vaginalis when a female partner has undiagnosed vaginal discharge. [1]
- Screening for other STIs, especially Chlamydia trachomatis/non-specific urethritis when circinate-type balanitis is present. [1]
- Dermatology opinion for suspected dermatoses or allergy. [1]
- Urological referral for circumcision planning or assessment for penile intraepithelial neoplasia or possible malignancy. [1]
- Biopsy when the diagnosis is uncertain or the condition persists. [1]
Hygiene and Supportive Measures
Genital skin care should focus on avoiding soaps and reducing irritant exposure. [1] Over-washing is a recognized predisposing factor, and counseling should include personal hygiene practices that avoid excessive cleaning. [1] Emollients should be encouraged as soap substitutes. [1] Patients should be warned about potential effects on condoms when creams are applied. [1] Predisposing factors should be optimized, including non-retractile foreskin and systemic conditions such as diabetes. [1]
Medication Selection Algorithm
Etiology-directed therapy should be selected based on clinical pattern and investigation results. [1] Topical imidazoles are recommended for candidal balanoposthitis. [1] Topical or systemic antimicrobials are selected for suspected bacterial or anaerobic infection based on severity and isolate/suspected organisms. [1] When inflammation is prominent in candidal disease, an imidazole combined with low-dose topical corticosteroid is recommended as an alternative option. [1] When diagnosis is uncertain or disease persists despite appropriate therapy, referral and escalation to biopsy evaluation should be pursued. [1]
Candidal Balanoposthitis Therapy
Hygiene measures are recommended for candidal balanoposthitis. [1] Topical therapy is recommended as first-line: [1]
- Clotrimazole cream 1% (Class I, Level A) applied twice daily for 7–14 days. [1]
-
Miconazole cream 2% (Level 2, Grade B) applied twice daily for 7–14 days. [1] Oral therapy is recommended as an alternative for severe symptoms: [1]
-
Fluconazole 150 mg orally as a single stat dose (Class I, Level A). [1] Alternative topical therapy options include the following: [1]
-
Nystatin cream 100,000 units/g applied as an alternative when resistance is suspected or when there is allergy to imidazoles (Level 2, Grade B). [1]
- Topical imidazole with hydrocortisone 1% when marked inflammation is present (Level 2, Grade D). [1] Sexual partner treatment may be considered for symptomatic partners given a high rate of candidal infection in sexual partners. [1]
Bacterial (Aerobic) Infection Therapy
Aerobic infection is suggested by erythema with edema and purulent discharge. [1] Diagnosis should depend on isolation of causative organisms from sub-preputial culture. [1] For milder cases, hygiene measures and topical treatment may be sufficient. [1] For more severe cases, systemic antibiotics may be required while awaiting culture results, guided by sensitivities. [1] Recommended topical regimens include the following: [1]
- Mupirocin ointment 2–3 times per day for 7–10 days. [1]
-
Trimovate cream once or twice daily for 7–10 days. [1] Oral therapy options used while awaiting swab results include the following: [1]
-
Oral phenoxymethylpenicillin 500 mg four times daily for 10 days. [1]
- Oral clarithromycin 250 mg twice daily for 7 days. [1]
Anaerobic Infection Therapy
Anaerobic infection is suggested by foul-smelling odor and sub-preputial discharge, with superficial erosions, edema, and tender lymphadenopathy in severe cases, and phimosis is associated. [1] Recommended therapy includes the following regimen: [1]
-
Metronidazole 400–500 mg twice daily for 1 week (Level 1, Grade D). [1] Topical treatment may be adequate for milder cases. [1] Alternative regimens include the following: [1]
-
Co-amoxiclav 375 mg three times daily for 1 week. [1]
- Clindamycin cream applied twice daily until resolved. [1]
Treatment Duration, Response, and Escalation
Imidazole topical therapy for candidal balanoposthitis is typically prescribed for 7–14 days. [1] If symptoms persist or diagnosis remains uncertain, further workup including consideration of biopsy is recommended. [1] Referral is recommended for suspected dermatoses/allergy, for urological assessment in the setting of penile intraepithelial neoplasia or possible malignancy, and for persistent diagnostic uncertainty. [1]
Special Considerations for Underlying Conditions
Diabetes should be considered in candidal balanoposthitis, and urinalysis for glucose is recommended in most cases and especially when candidal infection is suspected. [1] Non-retractile foreskin should be assessed as a contributing factor, and circumcision should be discussed when indicated to prevent recurrence. [1] When ulcers are present, viral and syphilis testing should be incorporated into the diagnostic workup. [1] Biopsy should be used to exclude penile intraepithelial neoplasia when diagnostic uncertainty exists or when disease persists. [1]